Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy

Cancer Clinical Trial

— TelOG  

Official title:

Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02583035
• Other study ID #: TelOG
• Status: Completed
• Phase: N/A
• Start date: February 2015
• Est. completion date: May 14, 2018

Study information

• Verified date: January 2019
• Source: Centre Francois Baclesse
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

There are no recommendations and few studies on the monitoring of fragile patients in the oncological treatment, both on the organizational arrangements on its interest in the prevention of functional deterioration of the patient and adaptation of the potential cancer treatment.

The oncogériatrique evaluation being time-consuming, requiring the movement of these more or less frail elderly patients, it seems difficult to envisage repeated and systematic standardized geriatric assessments during cancer treatment. Geriatric fragility can be detected by telephone. Craven et al. has already assessed the telephone follow-up by a nurse in patients treated for cancer, but with the aim to detect toxicities of cancer treatment, patients are not very old (mean age 64.8 years).

External evaluation by the nurse coordinator of UCOG (Coordination Unit in geriatric oncology) not knowing the patients included avoids bias of subjectivity in the interrogation.

However the telephone monitoring, with the aim to evaluate the evolution of geriatric frailty, has not been specifically studied in the elderly population treated for cancer, while taking oncology load.

The investigators wish to study the feasibility and validity of telephone follow-up which could eventually be used routinely to identify patients requiring further medical consultation oncogériatrique.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 131
• Est. completion date: May 14, 2018
• Est. primary completion date: February 16, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 70 Years and older

Eligibility

Inclusion Criteria:

• Patients 70 years and older with cancer or hematologic malignancies;

• Faced benefit from cancer treatment (systemic treatment, curative radiotherapy) in one of the clinical sites;

• Addressed in onco-gériatric consultation in the usual routine care sector;

• Mastery of the French language;

• Patient affiliated to the social security system;

• Patient has given its written consent.

Exclusion Criteria:

• Life expectancy <3 months

• Inability to communicate by telephone (deafness, speech disorder, ..)

• Inability collection of written consent

• Group 4 SiO (International Society of Geriatric Oncology), Performance status (PS) 4

• initial MMSE (Mini-Mental State Examination) <18/30

• oncological treatment envisaged: analgesic radiotherapy or exclusive decompressive, brain radiation therapy in toto

• Patient under guardianship

Related Conditions & MeSH terms

• Cancer
• Hematologic Malignancy
• Hematologic Neoplasms
• Neoplasms

Intervention

Other:
• Nurse telephone contact
Nurse will contact patient 3 days before consultation

Locations

Country	Name	City	State
France	Centre Hospitalier	Bayeux
France	Centre François Baclesse	Caen
France	CHU	Caen
France	Centre Hospitalier	Dieppe
France	Centre Hospitalier du Havre	Le Havre

Sponsors (1)

Lead Sponsor	Collaborator
Centre Francois Baclesse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Memory on the Mini Mental Scale		3 months after inclusion
Primary	Falls on the number of falls		3 months after inclusion
Primary	Pain on the EVS (verbal scale) scale		3 months after inclusion
Primary	Autonomy on the ADL (activities of daily living) score		3 months after inclusion
Primary	Pain on the EN (numericale scale) scale		3 months after inclusion
Primary	Autonomy on the IADL (The Lawton Instrumental Activities of Daily Living Scale ) score		3 months after inclusion